Skip to main content
. 2026 Oct 30;17:1996037. doi: 10.3389/fmicb.2026.1996037

Table 2.

Representative CRISPR/Cas-based engineering strategies in probiotic and beneficial microorganisms: functional outcomes, application relevance, and experimental validation context.

Microorganism/Strain CRISPR/Cas strategy Genetic target/modification Main outcome Relevance to probiotic/validation context Ref.
Lactobacillus crispatus NCK1350 Endogenous type I-E CRISPR-Cas Targeted deletions, nucleotide substitution and chromosomal insertion, including p-gtf editing 643-bp p-gtf deletion reached 100% efficiency; stop-codon insertion, single-nucleotide substitution, prophage-region deletion and gfp integration were also achieved Established an endogenous editing platform for functional genomics and engineering of a beneficial/probiotic-associated species/without demonstrated food-related performance Hidalgo-Cantabrana et al. (2019)
Limosilactobacillus reuteri ATCC PTA 6475 CRISPR-Cas9-assisted ssDNA recombineering Sequence-specific chromosomal edits at multiple loci CRISPR counterselection increased recovery of desired edits to 90–100% for three tested targets and enabled codon-level mutagenesis High-efficiency genome-engineering platform for a probiotic LAB/ no food-matrix assessment Oh and van Pijkeren (2014)
Limosilactobacillus reuteri 03 Endogenous type II-A CRISPR-Cas9 Gene deletion, point mutation, large-fragment deletion and gene integration Editing efficiencies reached 95.46% for deletion and 86.36% for point mutation; a 40-kb deletion and 1,743-bp integration (73.9%) were demonstrated Advanced endogenous editing platform for development of a probiotic chassis and live biotherapeutic products/ without demonstrated functional efficacy Guo et al. (2023)
Lacticaseibacillus casei LC2W CRISPR-Cas9D10A nickase (pLCNICK) In-frame deletion of four genes and chromosomal eGFP insertion Targeted deletions and insertions were achieved with efficiencies of 25–62% in a one-step workflow Rapid and precise genome engineering in a health-promoting and food-associated LAB/ no technological phenotype or food-matrix validation Song et al. (2017)
Lactiplantibacillus plantarum AR113 CRISPR-Cas9 Single and multiple knoc-kout of bsh genes bsh genes differentially affected growth in bile-containing media, aggregation, surface properties and adhesion to HT-29 cells; bsh2 was linked to adhesion Functional identification of genetic determinants relevant to gastrointestinal fitness and colonization/ no evidence of improved probiotic efficacy Wu et al. (2022)
Lactiplantibacillus plantarum AR113 CRISPR-Cas9 Deletion of mucin/adhesion-associated genes, including Lp_1431, Lp_2233 and Lp_2792; chromosomal RFP labeling Triple deletion reduced adhesion to HT-29 cells from 175 to 114 bacteria/100 cells and shortened intestinal persistence in mice from 14 to 11 days; acid and bile tolerance were largely unchanged Functional dissection of determinants of adhesion and intestinal persistence/ not food-process validation Qin et al. (2022)
Lactiplantibacillus plantarum WCFS1 and SPC 72-1; Levilactobacillus brevis SPC-SNU 70–2 Cas9-gRNA ribonucleoprotein (RNP) + RecE/T 50-bp deletion and stop-codon introduction in hlyIII ΔhlyIII mutants were obtained in all three strains; free hemoglobin levels decreased by 27.0%, 74.3 and 5.0%, respectively, although the functional role of hlyIII requires further validation Demonstrates transient RNP-based Cas9 delivery that reduces reliance on plasmid-borne CRISPR components; the functional role of hlyIII and its relevance to strain safety require further validation Kim et al. (2025)
Lactiplantibacillus plantarum WCFS1 Inducible two-plasmid CRISPR-Cas9 knock-in system Chromosomal insertion of mCherry reporter and SARS-CoV-2 receptor-binding domain expression cassettes (~0.8–1.3 kb) Stable chromosomal insertion enabled inducible or constitutive expression of heterologous proteins in the cytoplasm or on the cell surface Demonstrates the capacity of L. plantarum to serve as a genetically stable delivery chassis for functional heterologous proteins/ not food-related validation Wiull et al. (2025)
Clostridium butyricum Heterologous type II CRISPR-Cas9 and endogenous type I-B CRISPR-Cas Targeted deletion of spo0A and aldh The endogenous type I-B system enabled seamless deletion with efficiencies up to 100%; heterologous Cas9 imposed a strong transformation burden Expanded the genetic toolbox for a probiotic anaerobe and highlighted advantages of endogenous systems/ technological performance not assessed Zhou et al. (2021)
Clostridium butyricum CRISPR-Cas12a Scarless genome manipulation, anaerobic reporter system, plasmid curing and acetaldehyde-pathway engineering Markerless editing was established; aldh overexpression increased enzyme activity by 79.29% as a proof of concept Advanced platform for functional and metabolic engineering under strict anaerobic conditions/ no food-matrix validation Li D. et al. (2026)
Bifidobacterium animalis subsp. lactis Endogenous type I-G CRISPR-Cas and CRISPR cytosine base editor 500-bp deletion and nonsense mutation of tetW; additional genomic edits tetW deletion abolished tetracycline resistance; C-to-T base editing restored tetracycline susceptibility in multiple strains Direct example of removing an undesirable antimicrobial-resistance phenotype from probiotic bifidobacteria/ food-use safety requires separate evaluation Pan et al. (2022)
Bifidobacterium animalis AR668 CRISPR-Cas9 Knockout of genes 0348 and 0208; homology-arm optimisation and inducible plasmid curing Successful targeted knockouts and establishment of an inducible plasmid-curing system Provides a platform for functional-genetic analysis and rational modification of bifidobacteria/without food-process validation Li et al. (2023)
Bifidobacterium longum, B. adolescentis, B. pseudocatenulatum and related strains CRISPR-Cas9 cytosine base editor (cBEST) DSB-free C-to-T base editing; disruption of conserved metabolic targets Restriction-modification bypass markedly improved editing efficiency, and the same editing design was portable across several Bifidobacterium species Expands precision editing for probiotic bifidobacteria while avoiding double-strand breaks/ no direct food-related functional performance demonstrated Lin et al. (2025)
Bifidobacterium breve and other bifidobacterial species CRISPRi using nuclease-dead Cas9 orthologs Targeted repression of reporter genes and endogenous genes involved in nucleotide and carbohydrate metabolism A one-plasmid CRISPRi platform achieved efficient gene repression across multiple bifidobacterial species without extensive strain-specific optimisation Portable functional-genomics platform for commercially important and health-associated bifidobacteria/functional-genomics tool rather than a food-application study Friess et al. (2025)
Bifidobacterium animalis subsp. lactis (six commercial strains) Endogenous type I-G CRISPR-Cas Knockout of glycoside hydrolases within the Balac_1593–Balac_1601 cluster Editing was validated across six commercial strains; Balac_1601 deletion abolished melibiose and raffinose utilization, and sequential editing was demonstrated Enables genotype–phenotype mapping and future strain improvement directly in commercial probiotic strains; no food-matrix performance assessment Raftopoulou et al. (2026)
Lacticaseibacillus rhamnosus GG (LGG) Endogenous type II-A CRISPR-Cas Targeted deletions and insertions; chromosomal gusA integration Editing efficiencies of 11.1–25.0% were obtained, and a stable GUS-positive LGG reporter strain was generated for tracking in complex communities Enables investigation of probiotic persistence and provides a platform for functional strain construction/ no demonstrated improvement in probiotic efficacy Xie et al. (2026)
Levilactobacillus brevis EG040 CRISPR/Cas9 genome editing gadR overexpression; norG deletion gadR overexpression increased GABA secretion by 37.9% and survival in simulated gastric solution by 19%; norG deletion reduced GABA secretion by 97.3% and impaired growth Engineering of a food-derived GABA-producing LAB; links GABA biosynthesis with a probiotic-relevant stress-resistance phenotype/no direct validation in a food matrix reported Jo et al. (2026)
Escherichia coli Nissle 1917 (EcN) Engineered type I-E CRISPR-Cas3 CRISPR targeting of mcr-1, blaNDM-1 and tet(X) Engineered EcN efficiently blocked acquisition of targeted ARGs in vitro and showed immunity to their transfer in the zebrafish intestine CRISPR itself provides a defined protective function to a probiotic chassis/ no food-system validation Fang et al. (2024)
Escherichia coli Nissle 1917 (EcN) Prime editing (Cas9 nickase + reverse transcriptase + pegRNA) Precise substitutions, insertions and deletions; genomic barcoding; ARG-free chassis construction Prime editing enabled precise genome modification and construction of a barcoded, antibiotic-resistance-gene-free probiotic platform Extends probiotic engineering to programmable precision editing with a limited genomic footprint/probiotic efficacy and food-related performance not evaluated Chen et al. (2025)
Escherichia coli Nissle 1917 (EcN) Compact BLCas9 from a type II-C system of Bifidobacterium longum Dual-plasmid genome editing and targeted metabolic engineering Robust/multiplex editing was established, and extracellular GABA production was enhanced Designer-probiotic example combining a probiotic chassis with an engineered bioactive metabolic function/food-matrix performance and health effects not established Liu et al. (2026)
Lactococcus lactis NZ9000 Inducible CRISPRi (dCas9) Single/multiple gene repression; identification of LLNZ_07335 as a bile salt hydrolase CRISPRi repressed gene expression by up to 99%; it identified a functional determinant of bile salt resistance Links functional genomics with a probiotic-relevant stress-tolerance trait in an important food-grade LAB/no food-process validation Xiong et al. (2020)
Lactococcus lactis NZ9000 Chromosomal and plasmid-based inducible CRISPRi Conditional silencing of acmA and the essential gene ybeY Chromosomal dCas9 integration reduced expression ~20-fold relative to plasmid expression, minimized leakage and enabled tightly controlled silencing of essential genes Tunable functional-genomics platform for food-grade and beneficial L. lactis/not demonstrated food-related performance Huang et al. (2025)
Lactococcus lactis NZ9000 CRISPR-Cas9 knock-in +Cre/loxP genome reduction Chromosomal integration of a high-activity uricase variant and genome streamlining The engineered strain reached 2.34 U/mL uricase activity and completely degraded ~500 μM urate within 20 h; moderate colonization was observed in mice Functional food-grade probiotic chassis with a defined therapeutic metabolic activity; relevant to designer probiotics/live biotherapeutics/ not a validated food application Tang et al. (2026)

The validation context describes the experimental setting reported for each study; using a food-associated microorganism does not, by itself, demonstrate performance in food production or food matrices. ARG, antimicrobial-resistance gene; Cas, CRISPR-associated protein; CRISPR, clustered regularly interspaced short palindromic repeats; dCas9, nuclease-deficient Cas9; DSB, double-strand break; EcN, Escherichia coli Nissle 1917; GABA, γ-aminobutyric acid; GH, glycoside hydrolase; GUS, β-glucuronidase; LGG, Lacticaseibacillus rhamnosus GG; pegRNA, prime-editing guide RNA; RBD, receptor-binding domain; RNP, ribonucleoprotein.